We promote cardiovascular research
We work together with highly prestigious research organisations with the aim of producing new and improved treatments for illnesses related to the heart and circulation.
Since 2005 we've been working with the CNIC to achieve three goals:
Integrate basic molecular genetic research and its application to patients.
Support young researchers.
Educate society in the importance of cardiovascular health.
Achievement: We've developed a pill that groups together in a single capsule (Trinomia®) the three main active ingredients of medication that must be taken by those who have suffered a heart attack. Production starts on the cardiovascular multi-pill in Spain.
Since 2012 we've been promoting a reliable system to register and analyse the results of cardiovascular surgery in Spain.
Since 2008 we collaborate in the study and application of genetics in cardiology. Genetic results allow complement clinical trials, often insufficient for diagnosis and customized treatment options. In this sense, this research is essential for early detection of the presence of cardivascular diseases.